
Iridex (IRIX) is scheduled to report 3rd quarter earnings on 11/17/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Iridex to post earnings of -$0.04 per share.
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| IRIX | Iridex | 0.69 | -0.25 | -26.84% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.69 | -26.84% |

Iridex (IRIX) is scheduled to report 3rd quarter earnings on 11/17/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Iridex to post earnings of -$0.04 per share.

Iridex (IRIX) announced the publication of a two-year clinical study demonstrating outcomes with transscleral laser therapy, or TLT, using MicroPulse Technology in patients with early, moderate, and advanced primary glaucoma.

An update from Iridex ( ($IRIX) ) is now available. On August 27, 2026, Iridex Corporation disclosed that it received a non‑compliance notice from Nasdaq after its common stock traded

Iridex (($IRIX)) has held its Q2 earnings call. Read on for the main highlights of the call. Iridex’s latest earnings call struck a cautious but constructive tone, as management balanced

Iridex (IRIX) has disclosed a new risk, in the Corporate Activity and Growth category. Iridex faces heightened governance risk as tensions emerge between a majority of its board and directors

Iridex (IRIX) is scheduled to report 2nd quarter earnings on 08/18/2026, after the market closes. Regarding Q2 estimates, Wall Street analysts expect Iridex to post earnings of -$0.01 per share.

Iridex (IRIX) is scheduled to report 2nd quarter earnings on 08/06/2026. Regarding Q2 estimates, Wall Street analysts expect Iridex to post earnings of -$0.01 per share. Revenue expectations are pegged

An update from Iridex ( ($IRIX) ) is now available. At Iridex Corporation’s 2026 Annual Meeting of Stockholders, reconvened on July 10 after an adjournment on June 12, shareholders elected

Iridex ( ($IRIX) ) has provided an announcement. On June 12, 2026, Iridex Corporation convened but immediately adjourned its 2026 annual meeting of stockholders without conducting any business, and plans

Iridex (($IRIX)) has held its Q1 earnings call. Read on for the main highlights of the call. Iridex’s latest earnings call painted a cautiously optimistic picture for investors, balancing steady
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Aug 19, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Nov 17, 2026After Close | $12.12M | $-0.04 | $12.64M | 0.09 | -3.39 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.